Cargando…
A meta-analysis and systematic review of the comorbidity between irritable bowel syndrome and bipolar disorder
Irritable bowel syndrome (IBS) and bipolar disorder (BD) are 2 distinct diseases but may share a similar pathophysiology. However, the comorbidity rate of these 2 diseases is unclear. Also, the current practice guidelines suggest prescribing antidepressants to IBS patients. However, this practice ma...
Autores principales: | Tseng, Ping-Tao, Zeng, Bing-Syuan, Chen, Yen-Wen, Wu, Ming-Kung, Wu, Ching-Kuan, Lin, Pao-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370825/ https://www.ncbi.nlm.nih.gov/pubmed/27537599 http://dx.doi.org/10.1097/MD.0000000000004617 |
Ejemplares similares
-
Significantly Higher Prevalence Rate of Asthma and Bipolar Disorder Co-Morbidity: A Meta-Analysis and Review Under PRISMA Guidelines
por: Wu, Ming-Kung, et al.
Publicado: (2016) -
Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMA
por: Tu, Kun-Yu, et al.
Publicado: (2016) -
Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other Antidepressants: A Meta-Analysis Following the PRISMA Guidelines
por: Li, Dian-Jeng, et al.
Publicado: (2016) -
Significantly higher peripheral fibroblast growth factor-2 levels in patients with major depressive disorder: A preliminary meta-analysis under MOOSE guidelines
por: Wu, Ching-Kuan, et al.
Publicado: (2016) -
Significant Effect of Valproate Augmentation Therapy in Patients With Schizophrenia: A Meta-analysis Study
por: Tseng, Ping-Tao, et al.
Publicado: (2016)